April 2 (Reuters) - Abbott Laboratories said on Tuesday the U.S. Food and Drug Administration has approved its heart valve repair device, which is designed for patients who are at risk of complications or death during surgery. (Reporting by Puyaan Singh; Editing by Shilpi Majumdar)